Cargando…
Emerging Factors Implicated in Fibrotic Organ–Associated Thrombosis: The Case of Two Organs
Thrombosis is at the heart of cardiovascular complications observed in specific diseases. A heightened thrombosis risk above that in general population in diseases such as myelofibrosis and chronic kidney disease implicates disease-specific mediators of thrombosis. This relative lack of information...
Autores principales: | Leiva, Orly, Bekendam, Roelof H., Garcia, Brenda D., Thompson, Cristal, Cantor, Alan, Chitalia, Vipul, Ravid, Katya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2019
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6598088/ https://www.ncbi.nlm.nih.gov/pubmed/31259299 http://dx.doi.org/10.1055/s-0039-1692204 |
Ejemplares similares
-
Mechanisms of platelet activation in cancer-associated thrombosis: a focus on myeloproliferative neoplasms
por: Bekendam, Roelof H., et al.
Publicado: (2023) -
Janus Kinase Signaling Pathway and Its Role in COVID-19 Inflammatory, Vascular, and Thrombotic Manifestations
por: Ravid, Jonathan D., et al.
Publicado: (2022) -
Lysyl oxidase inhibition in primary myelofibrosis: A renewed strategy
por: Piasecki, Andrew, et al.
Publicado: (2020) -
A mass spectrometric method for quantification of tryptophan-derived uremic solutes in human serum
por: Zhang, Anqi, et al.
Publicado: (2017) -
Cardiovascular Disease in Myeloproliferative Neoplasms: JACC: CardioOncology State-of-the-Art Review
por: Leiva, Orly, et al.
Publicado: (2022)